0
The U.S. Food and Drug Administration’s Center for Veterinary Medicine has published the 2024 Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals, the most recent annual summary of data submitted to the agency by animal drug sponsors as required under the Federal Food, Drug, and Cosmetic Act. The 2024 data indicate that U.S. sales and distribution of medically important antimicrobial drugs approved for use in food-producing animals increased by 16% between 2023 and 2024. This increase is a departure from the generally stable annual sales and distribution data reported to FDA since 2017. To put these numbers in historical context, the overall sales volume in 2024 is 27% below peak sales in 2015.
The total sales of antimicrobial drugs for use in swine increased by 13% in 2024.
Sales volume may fluctuate over time in response to various factors, including changing animal health needs, changes in animal populations, and changes in animal production practices. It is important to note that antimicrobial sales data do not necessarily reflect how much of the drugs are ultimately used in animals, only the volume that is sold.
December 5, 2025/ FDA/ United States.
https://www.fda.gov
